Gilead Sciences APAC News and Activities

Gilead Sciences APAC is owned by Gilead Sciences.

Gilead Sciences is one of the...

• Forbes Global 2000 (#233);
• Fortune 500 (#153);
• Nasdaq 100;
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Gilead Sciences is a company listed under the stock ticker GILD (US).

Gilead Sciences has a direct presence in 8 countries.

Gilead Sciences has 10 subsidiaries including Arcellx, Gilead Sciences APAC and Gilead Sciences Canada.

They are in:

• Pharmaceuticals55%
• Biotechnology45%

Acquisition, funding and merger involving Gilead Sciences.

• Gilead Sciences has acquired Tubulis (posted on May 21 2026).
• Gilead Sciences has acquired Arcellx (posted on April 28 2026).
• Gilead Sciences has announced the acquisition of Tubulis  (posted on April 16 2026).
• Gilead Sciences has announced the acquisition of Ouro Medicines  (posted on March 24 2026).
• See more news about Gilead Sciences Hide news involving Gilead Sciences

View the org chart displaying its 6 main executives

Most searched biographies at Gilead Sciences APAC

• Jim Jin, Vice President, General Managr, China
• Andrew Hexter, President and Representative Director, Japan
• Deepshikha Kiyawat, General Manager, India

Popular executive movements at Gilead Sciences

• Divya Dhankhar has joined the company as Director, Global Digital Innovation and Artificial Intelligence  (posted on June 30 2026).
• Scott Nunn, Senior Director, Packaging and Labeling Development, has left the company  (posted on June 18 2026).
• Kimberly Jablonski has joined the company as Senior Vice President, Global Legal Business Partners  (posted on June 18 2026).

Click here to view some more movements at Gilead Sciences

Create your alert
to follow the executive moves at Gilead Sciences APAC.

Gilead Sciences has 1,919 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna

Learn more about the Pharmaceuticals industry

Press releases by Gilead Sciences APAC

Social media about Gilead Sciences APAC

• Gilead Sciences APAC on Wikipedia, Google News & Yahoo Finance
• Gilead Sciences APAC on LinkedIn, X (Twitter) & YouTube